home / stock / otsky / otsky quote
Last: | $20.65 |
---|---|
Change Percent: | -0.15% |
Open: | $20.5 |
Close: | $20.65 |
High: | $20.65 |
Low: | $20.39 |
Volume: | 50,104 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$20.65 | $20.5 | $20.65 | $20.65 | $20.39 | 50,104 | 04-29-2024 |
$20.47 | $20.35 | $20.47 | $20.47 | $20.25 | 33,589 | 04-26-2024 |
$20.03 | $19.94 | $20.03 | $20.09 | $19.93 | 34,904 | 04-25-2024 |
$20.38 | $20.4075 | $20.38 | $20.42 | $20.33 | 34,796 | 04-24-2024 |
$20.57 | $19.83 | $20.57 | $20.57 | $19.83 | 69,000 | 04-23-2024 |
$20.45 | $20.686 | $20.45 | $20.755 | $20.38 | 38,374 | 04-22-2024 |
$20.2 | $20.5375 | $20.2 | $20.67 | $20.012 | 56,493 | 04-19-2024 |
$19.96 | $20.25 | $19.96 | $20.25 | $19.91 | 26,001 | 04-18-2024 |
$20.19 | $20.04 | $20.19 | $20.28 | $20.04 | 80,526 | 04-17-2024 |
$20.47 | $20.49 | $20.47 | $20.49 | $20.43 | 32,432 | 04-16-2024 |
$20.38 | $20.67 | $20.38 | $20.67 | $20.37 | 37,300 | 04-15-2024 |
$20.5 | $20.621 | $20.5 | $20.7 | $20.496 | 16,559 | 04-12-2024 |
$20.55 | $20.52 | $20.55 | $20.59 | $20.41 | 34,504 | 04-11-2024 |
$20.54 | $20.61 | $20.54 | $20.63 | $20.47 | 50,576 | 04-10-2024 |
$20.5 | $20.66 | $20.5 | $20.66 | $20.43 | 150,219 | 04-09-2024 |
$20.67 | $20.61 | $20.67 | $20.7 | $20.58 | 25,317 | 04-08-2024 |
$20.54 | $20.5 | $20.54 | $20.6 | $20.5 | 38,294 | 04-05-2024 |
$20.6 | $20.83 | $20.6 | $20.88 | $20.6 | 56,771 | 04-04-2024 |
$21.04 | $21.01 | $21.04 | $21.175 | $21.01 | 109,457 | 04-03-2024 |
$20.9 | $21 | $20.9 | $21.34 | $20.85 | 23,509 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Otsuka Holdings Co. Ltd. ADR Company Name:
OTSKY Stock Symbol:
OTCMKTS Market:
Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associ...
Wednesday, IGC Pharma Inc (NYSE:IGC) announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation i...
Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has nosedived in price since its market debut. In addition, given an ongoing investigation into the com...